vs

Side-by-side financial comparison of RAYONIER ADVANCED MATERIALS INC. (RYAM) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

RAYONIER ADVANCED MATERIALS INC. is the larger business by last-quarter revenue ($417.5M vs $220.8M, roughly 1.9× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs -5.0%, a 10.9% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs -1.2%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 3.8%).

Rayonier Advanced Materials recently rebranded as RYAM. RYAM is an American company recognized globally for its cellulose-based technologies. Specializing in high-purity cellulose specialties, RYAM produces natural polymers extensively used in manufacturing filters, food, pharmaceuticals, and various industrial applications. Additionally, the company produces products for the paper and packaging industries. The company is publicly traded on the New York Stock Exchange under the ticker symbol ...

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

RYAM vs UTI — Head-to-Head

Bigger by revenue
RYAM
RYAM
1.9× larger
RYAM
$417.5M
$220.8M
UTI
Growing faster (revenue YoY)
UTI
UTI
+10.8% gap
UTI
9.6%
-1.2%
RYAM
Higher net margin
UTI
UTI
10.9% more per $
UTI
5.8%
-5.0%
RYAM
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
3.8%
RYAM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
RYAM
RYAM
UTI
UTI
Revenue
$417.5M
$220.8M
Net Profit
$-21.1M
$12.8M
Gross Margin
8.9%
Operating Margin
2.6%
7.1%
Net Margin
-5.0%
5.8%
Revenue YoY
-1.2%
9.6%
Net Profit YoY
-31.9%
-42.1%
EPS (diluted)
$-0.33
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RYAM
RYAM
UTI
UTI
Q4 25
$417.5M
$220.8M
Q3 25
$352.8M
$222.4M
Q2 25
$340.0M
$204.3M
Q1 25
$356.0M
$207.4M
Q4 24
$422.5M
$201.4M
Q3 24
$401.1M
$196.4M
Q2 24
$419.0M
$177.5M
Q1 24
$387.7M
$184.2M
Net Profit
RYAM
RYAM
UTI
UTI
Q4 25
$-21.1M
$12.8M
Q3 25
$-4.5M
$18.8M
Q2 25
$-363.2M
$10.7M
Q1 25
$-32.0M
$11.4M
Q4 24
$-16.0M
$22.2M
Q3 24
$-32.6M
$18.8M
Q2 24
$11.4M
$5.0M
Q1 24
$-1.6M
$7.8M
Gross Margin
RYAM
RYAM
UTI
UTI
Q4 25
8.9%
Q3 25
9.7%
Q2 25
7.0%
Q1 25
6.8%
Q4 24
8.7%
Q3 24
10.9%
Q2 24
11.5%
Q1 24
9.5%
Operating Margin
RYAM
RYAM
UTI
UTI
Q4 25
2.6%
7.1%
Q3 25
2.8%
11.2%
Q2 25
-0.4%
6.9%
Q1 25
-4.2%
8.1%
Q4 24
2.6%
13.6%
Q3 24
-4.2%
13.3%
Q2 24
6.7%
4.2%
Q1 24
4.4%
6.1%
Net Margin
RYAM
RYAM
UTI
UTI
Q4 25
-5.0%
5.8%
Q3 25
-1.3%
8.4%
Q2 25
-106.8%
5.2%
Q1 25
-9.0%
5.5%
Q4 24
-3.8%
11.0%
Q3 24
-8.1%
9.6%
Q2 24
2.7%
2.8%
Q1 24
-0.4%
4.2%
EPS (diluted)
RYAM
RYAM
UTI
UTI
Q4 25
$-0.33
$0.23
Q3 25
$-0.07
$0.33
Q2 25
$-5.44
$0.19
Q1 25
$-0.49
$0.21
Q4 24
$-0.25
$0.40
Q3 24
$-0.49
$0.35
Q2 24
$0.17
$0.09
Q1 24
$-0.02
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RYAM
RYAM
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$75.4M
$162.8M
Total DebtLower is stronger
$758.1M
$101.4M
Stockholders' EquityBook value
$316.6M
$335.9M
Total Assets
$1.8B
$834.0M
Debt / EquityLower = less leverage
2.39×
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RYAM
RYAM
UTI
UTI
Q4 25
$75.4M
$162.8M
Q3 25
$77.0M
$169.1M
Q2 25
$70.7M
$70.7M
Q1 25
$129.9M
$96.0M
Q4 24
$125.2M
$172.0M
Q3 24
$136.1M
$161.9M
Q2 24
$114.1M
$115.5M
Q1 24
$54.6M
$116.1M
Total Debt
RYAM
RYAM
UTI
UTI
Q4 25
$758.1M
$101.4M
Q3 25
$763.5M
$87.1M
Q2 25
$720.4M
$73.8M
Q1 25
$707.0M
$94.4M
Q4 24
$706.4M
$120.1M
Q3 24
$747.7M
$125.7M
Q2 24
$752.8M
$137.3M
Q1 24
$755.6M
$141.9M
Stockholders' Equity
RYAM
RYAM
UTI
UTI
Q4 25
$316.6M
$335.9M
Q3 25
$338.2M
$328.1M
Q2 25
$342.3M
$306.8M
Q1 25
$688.1M
$293.9M
Q4 24
$713.9M
$280.0M
Q3 24
$732.7M
$260.2M
Q2 24
$755.1M
$239.4M
Q1 24
$741.8M
$232.6M
Total Assets
RYAM
RYAM
UTI
UTI
Q4 25
$1.8B
$834.0M
Q3 25
$1.8B
$826.1M
Q2 25
$1.8B
$740.8M
Q1 25
$2.1B
$720.4M
Q4 24
$2.1B
$753.8M
Q3 24
$2.2B
$744.6M
Q2 24
$2.2B
$706.0M
Q1 24
$2.1B
$702.1M
Debt / Equity
RYAM
RYAM
UTI
UTI
Q4 25
2.39×
0.30×
Q3 25
2.26×
0.27×
Q2 25
2.10×
0.24×
Q1 25
1.03×
0.32×
Q4 24
0.99×
0.43×
Q3 24
1.02×
0.48×
Q2 24
1.00×
0.57×
Q1 24
1.02×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RYAM
RYAM
UTI
UTI
Operating Cash FlowLast quarter
$32.3M
$3.1M
Free Cash FlowOCF − Capex
$-19.2M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
10.1%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RYAM
RYAM
UTI
UTI
Q4 25
$32.3M
$3.1M
Q3 25
$-17.8M
$57.1M
Q2 25
$-30.2M
$18.1M
Q1 25
$39.6M
$-789.0K
Q4 24
$54.9M
$23.0M
Q3 24
$49.8M
$67.5M
Q2 24
$87.6M
$10.0M
Q1 24
$11.3M
$-2.5M
Free Cash Flow
RYAM
RYAM
UTI
UTI
Q4 25
$-19.2M
Q3 25
$40.6M
Q2 25
$6.8M
Q1 25
$-11.7M
Q4 24
$19.6M
Q3 24
$60.0M
Q2 24
$3.0M
Q1 24
$-8.4M
FCF Margin
RYAM
RYAM
UTI
UTI
Q4 25
-8.7%
Q3 25
18.3%
Q2 25
3.4%
Q1 25
-5.7%
Q4 24
9.7%
Q3 24
30.6%
Q2 24
1.7%
Q1 24
-4.6%
Capex Intensity
RYAM
RYAM
UTI
UTI
Q4 25
10.1%
Q3 25
7.4%
Q2 25
5.5%
Q1 25
5.3%
Q4 24
1.7%
Q3 24
3.8%
Q2 24
4.0%
Q1 24
3.2%
Cash Conversion
RYAM
RYAM
UTI
UTI
Q4 25
0.24×
Q3 25
3.04×
Q2 25
1.69×
Q1 25
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
7.69×
2.01×
Q1 24
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RYAM
RYAM

Cellulose Specialties$249.6M60%
Other$86.2M21%
Paperboard$44.2M11%
High Yield Pulp$28.3M7%
Biomaterials$9.2M2%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons